Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-19T07:13:29.726Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost-effectiveness of an education and activation program for patients with acute and subacute shoulder complaints compared to usual care

Published online by Cambridge University Press:  18 January 2007

Camiel De Bruijn ,
Marielle Goossens ,
Rob de Bie ,
Andre Ament ,
Jacques Geraets  and
Geert-Jan Dinant
Camiel De Bruijn
Affiliation:
Maastricht UniversityandInstitute for Rehabilitation Research
Marielle Goossens
Affiliation:
Maastricht University
Rob de Bie
Affiliation:
Maastricht University
Andre Ament
Affiliation:
Maastricht University
Jacques Geraets
Affiliation:
Maastricht UniversityandInstitute for Rehabilitation Research
Geert-Jan Dinant
Affiliation:
Maastricht University
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: Shoulder complaints (SCs) constitute the second largest group of musculoskeletal disorders after low back pain. The economic burden in terms of costs of healthcare use and costs due to work absenteeism underlines the need for a cost-effectiveness analysis of the interventions involved. The education and activation program (EAP) is a newly developed early intervention to prevent the development of chronic SCs. A cost-effectiveness analysis should provide more information on the effect of an EAP on total costs related to SCs.

Methods: We conducted a cost-effectiveness analysis alongside a randomized clinical trial comparing the effectiveness of the EAP in addition to usual care (EAP group) with that of usual care alone (UC group) in terms of preventing chronicity in patients with acute SCs. The aim of the cost-effectiveness analysis was to compare the observed difference in costs with the clinical effectiveness (i.e., patient-perceived recovery after 26 weeks), using bootstraps.

Results: The comparison of total costs between treatment groups showed no significant (p = .077) difference after 26 weeks. The majority (82 percent) of the cost-effect pairs after bootstrap analysis were located in the northeast quadrant, suggesting more effect but at higher costs.

Conclusions: In view of the clinical relevance of the clinical outcomes and the considerable costs needed to achieve this, it can be concluded that the EAP is currently not cost-effective.

Keywords

Education and activation programShoulder complaintsCost-effectivenessRandomized clinical trialBootstrap analysis
Type
GENERAL ESSAYS
Information
International Journal of Technology Assessment in Health Care , Volume 23 , Issue 1 , January 2007 , pp. 80 - 88
Copyright
© 2007 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bergman GJD. et al. 2004: Economic evaluation. In: Bergman GJD, ed. Manipulative therapy for shoulder complaints in general practice. Amsterdam: Groningen; 63– 77.
Black WC. 1990 The CE plane: A graphic representation of cost-effectiveness. Med Decis Making. 10: 212– 214.Google Scholar
Briggs AH, Gray AM. 1999 Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 3: 1– 134.Google Scholar
Briggs AH, Wonderling DE, Mooney CZ. 1997 Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ. 6: 327– 340.Google Scholar
Brooks R. 1996 EuroQol: The current state of play. Health Policy. 37: 53– 72.Google Scholar
Bruijn CD, de Bie R, Geraets J. 2005 Evaluation of an education and activation programme to prevent chronic shoulder complaints: Design of an RCT (ISRCTN71777817). BMC Fam Pract. 6: 7.Google Scholar
Chaudhary MA, Stearns SC. 1996 Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Stat Med. 15: 1447– 1458.Google Scholar
Efron B, Tibshirani RJ. 1993. An introduction to the bootstrap. New York: Chapmann and Hall.
Fordyce WE. 1976. Behavioral methods for chronic pain and illness. Saint Louis: C.V. Mosby Company;
Geraets JJ, Goossens ME, de Bruijn CP. 2006 Cost-effectiveness of a graded exercise therapy program for patients with chronic shoulder complaints. Int J Technol Assess Health Care. 22: 76– 83.Google Scholar
Goossens M, Evers SMAA. 1997 Economic evaluation in back pain interventions. J Occup Rehabil. 7: 15– 32.Google Scholar
Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM. 2000 The cost diary: A method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol. 53: 688– 695.Google Scholar
Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. 1995 The friction cost method for measuring indirect costs of disease. J Health Econ. 14: 171– 189.Google Scholar
Kuijpers T, van der Windt DA, Boeke AJ, et al. 2006 Clinical prediction rules for the prognosis of shoulder pain in general practice. Pain. 120: 276– 285.Google Scholar
Linton S. 2000 A systematic review of psychological risk factors for back and neck pain. Spine. 25: 1148– 1156.Google Scholar
Meerding WJ, Bonneux L, Polder JJ, Koopmanschap MA, van der Maas PJ. 1998 Demographic and epidemiological determinants of healthcare costs in Netherlands: Cost of illness study. BMJ. 317: 111– 115.Google Scholar
Nygren A, Berglund A, von Koch M. 1995 Neck-and-shoulder pain, an increasing problem. Strategies for using insurance material to follow trends. Scand J Rehabil Med Suppl. 32: 107– 112.Google Scholar
Oostenbrink JB, et al. 2004. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen;
Picavet HSJ, Schouten JSAG. 2003 Musculoskeletal pain in the Netherlands: Prevalences, consequences and risk groups, the DMC(3)-study. Pain. 102: 167– 178.Google Scholar
Turk DC. 1997. The role of demographic and psychosocial factors in transition from acute to chronic pain. In 8th World Congress on Pain, Progress in Pain Research and Management. Seattle, WA: IASP Press;
van der Windt DA, Koes BW, Boeke AJ, et al. 1996 Shoulder disorders in general practice: prognostic indicators of outcome. Br J Gen Pract. 46: 519– 523.Google Scholar
van Hout BA, Al MJ, Gordon GS, Rutten FF. 1994 Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 3: 309– 319.Google Scholar
van Loenen AC. 2003. Farmacotherapeutisch Kompas. Amstelveen: College voor zorgverzekeringen;
Waddell G. 1998: The back pain revolution. London: Churchill Livingstone; 103– 117; 351– 367.
Weiser S, Cedraschi C. 1992 Psychosocial issues in the prevention of chronic low back pain - A literature review. Baillieres Clin Rheumatol. 6: 657– 684.Google Scholar
Winters JC, et al. 1999; NHG-Standaard Schouderklachten. Huisarts en Wetenschap. 42: 222– 231.